Aria Neurosciences was one of three winning entrants at the Massachusetts Life Sciences Innovation Day June 8 in Boston.

The poster “Novel Disease Modifying Therapy for Alzheimer’s Disease” was presented by Mark Findeis, PhD, VP Research and Bijan Almassian, PhD, CEO of Aria.

Aria, based in Hamden, is a preclinical-stage biopharmaceutical company dedicated to developing and commercializing novel disease modifying therapies for Alzheimer’s disease.